On December 28, 2020, the National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued a notice on the Release of the List of Drugs for National Basic Medical Insurance, Occupational Injury Insurance and Maternity Insurance (2020 Edition)（click to view）

Warm congratulations on Reflow?'s entry into the National Drug Reimbursement List!

The thrombolysis patency rate of Reflow is as high as 83%.

It only takes 5-10 seconds for a single injection to realize thrombolysis.

It brings more effective and timely treatment to patients with acute myocardial infarction (AMI).